Metropolitan Life Insurance Company (MetLife)’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-9,348
| Closed | -$674K | – | 2628 |
|
|
2020
Q4 | $674K | Sell |
9,348
-961
| -9% | -$50.3K | 0.01% | 1169 |
|
|
2020
Q3 | $470K | Hold |
10,309
| – | – | 0.01% | 1258 |
|
|
2020
Q2 | $466K | Sell |
10,309
-251
| -2% | -$11.2K | 0.01% | 1262 |
|
|
2020
Q1 | $407K | Buy |
10,560
+267
| +3% | +$12.3K | 0.01% | 1176 |
|
|
2019
Q4 | $477K | Sell |
10,293
-312
| -3% | -$13.5K | 0.01% | 1355 |
|
|
2019
Q3 | $432K | Hold |
10,605
| – | – | 0.01% | 1388 |
|
|
2019
Q2 | $511K | Hold |
10,605
| – | – | 0.01% | 1288 |
|
|
2019
Q1 | $664K | Hold |
10,605
| – | – | 0.01% | 1120 |
|
|
2018
Q4 | $633K | Buy |
10,605
+152
| +1% | +$9.13K | 0.01% | 1065 |
|
|
2018
Q3 | $674K | Sell |
10,453
-285
| -3% | -$15.9K | 0.01% | 1165 |
|
|
2018
Q2 | $483K | Hold |
10,738
| – | – | 0.01% | 1335 |
|
|
2018
Q1 | $333K | Buy |
10,738
+497
| +5% | +$16.3K | ﹤0.01% | 1536 |
|
|
2017
Q4 | $306K | Sell |
10,241
-9,291
| -48% | -$269K | ﹤0.01% | 1607 |
|
|
2017
Q3 | $645K | Hold |
19,532
| – | – | ﹤0.01% | 1518 |
|
|
2017
Q2 | $653K | Sell |
19,532
-1,744
| -8% | -$52K | ﹤0.01% | 1502 |
|
|
2017
Q1 | $616K | Hold |
21,276
| – | – | ﹤0.01% | 1523 |
|
|
2016
Q4 | $476K | Hold |
21,276
| – | – | ﹤0.01% | 1772 |
|
|
2016
Q3 | $395K | Hold |
21,276
| – | – | ﹤0.01% | 1852 |
|
|
2016
Q2 | $347K | Hold |
21,276
| – | – | ﹤0.01% | 1924 |
|
|
2016
Q1 | $249K | Hold |
21,276
| – | – | ﹤0.01% | 2042 |
|
|
2015
Q4 | $249K | Hold |
21,276
| – | – | ﹤0.01% | 2088 |
|
|
2015
Q3 | $260K | Sell |
21,276
-1,825
| -8% | -$23.3K | ﹤0.01% | 2097 |
|
|
2015
Q2 | $218K | Sell |
23,101
-498
| -2% | -$4.61K | ﹤0.01% | 2344 |
|
|
2015
Q1 | $209K | Hold |
23,599
| – | – | ﹤0.01% | 2037 |
|
|
2014
Q4 | $237K | Buy |
+23,599
| New | +$202K | ﹤0.01% | 2288 |
|
|
2014
Q3 | – | Sell |
-22,066
| Closed | -$158K | – | 2821 |
|
|
2014
Q2 | $158K | Buy |
+22,066
| New | +$176K | ﹤0.01% | 2638 |
|
Other funds holding BEAT
Metropolitan Life Insurance Company (MetLife)'s BEAT Position: Q1 2021 in Review
Metropolitan Life Insurance Company (MetLife) sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 9,348 shares — an estimated $674K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in BEAT in Q2 2014 and held it in 26 quarters. The position peaked at $674K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Metropolitan Life Insurance Company (MetLife) reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 9,348 BioTelemetry, Inc. shares in Q1 2021, an estimated $674K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in BioTelemetry, Inc. in Q2 2014 and held it in 26 quarters.
- Metropolitan Life Insurance Company (MetLife)'s BioTelemetry, Inc. position peaked at $674K in Q4 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2021, filed 14 May 2021.